Bryan Perozzi

Google DeepMind's C2S-Scale 27B, a 27 billion parameter foundation model built on Gemma, discovered a novel cancer immunotherapy pathway by predicting that silmitasertib acts as a conditional immune signal amplifier, a hypothesis later confirmed through experimental validation in living cells.

“Co-author of the Cell2Sentence-Scale 27B research article”